Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Differentiated Thyroid Carcinoma 1Adenocarcinoma, Follicular 1

Interventions

Specimen Handling 219Magnetic Resonance Spectroscopy 196pembrolizumab 195Carboplatin 169Cisplatin 137Biopsy 130Nivolumab 127Paclitaxel 112Cyclophosphamide 109Radiotherapy 104Gemcitabine 103durvalumab 88Dexamethasone 88atezolizumab 75Rituximab 69Radiation 67Lenalidomide 67Pemetrexed 65Doxorubicin 64Bevacizumab 64Docetaxel 61Etoposide 57Ipilimumab 56olaparib 54Fluorouracil 50Prednisone 49Oxaliplatin 49venetoclax 48Taxes 48Radiosurgery 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Iodine-124 × 90 days × Clear all
NCT01704586 2026-05-12

CLERAD-PROBE

University of Wuerzburg

Phase NA Active not recruiting
340 enrolled
EndocrineHead & Neck

Differentiated Thyroid Carcinoma

NCT02152995 2026-04-13

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
34 enrolled 18 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡